Intersect VC

Intersect VC is a US-based venture capital firm focused on early-stage investments, primarily in technology-driven sectors. With a particular interest in fintech, consumer products, enterprise software, and blockchain, the fund backs startups that aim to disrupt traditional industries through innovative solutions. They typically engage at seed and Series A stages, showing a preference for ventures with clear paths to growth. Intersect VC has a modest yet diverse portfolio, including companies like Juvena Therapeutics in healthcare, Masa in blockchain, and ROW8 in digital media. Although the fund has been selective, it ensures deep engagement with its portfolio companies, often co-investing alongside other notable funds, such as Unshackled Ventures and Mubadala. This collaborative approach highlights their strategy of leveraging partnerships to support portfolio growth. The firm’s team, led by Kyle Ellicott as a Partner, brings a blend of entrepreneurial experience and investment acumen, focusing on helping startups navigate early challenges. Based out of California, Intersect VC provides not just capital but also mentorship, connecting startups with industry networks that accelerate their market entry. Entrepreneurs can reach out to Intersect VC by demonstrating a strong product-market fit, scalable technology, and a clear value proposition. They prioritize founders who are agile, capable of adapting to market needs, and are transparent about their long-term vision.